WeVote
Log In

Bill

Bill

HB 2456

Modifies provisions relating to infectious or communicable diseases

2026 Regular Session Introduced by Lilly Fuchs

Missouri Bill 2456 repeals HIV-specific laws and replaces them with broader infectious or communicable disease rules, expanding testing, infection control, and regulatory guidance

Referred: Emerging Issues(H)
#healthcare #health #public
0
WeVote Research Nonpartisan
Bill Summary · HB 2456

Overview

House Bill 2456 (2026) from Missouri repeals a broad set of existing HIV/AIDS-related statutes and replaces them with fourteen new sections focused on infectious or communicable diseases more generally. The measure shifts away from HIV-specific requirements toward broader testing, infection control, and regulatory frameworks for health care and related industries. It also updates certain provisions in pharmacy practice, insurance genetic testing, real estate disclosures, and criminal justice-related testing.

Main purpose and intent

  • Reframe Missouri law to address infectious or communicable diseases more broadly, not solely HIV.
  • Remove many HIV-specific statutory requirements and replace them with generalized “serious infectious or communicable disease” standards.
  • Expand and codify infection control, testing, and certain public health protocols across health care, corrections, mental health, insurance, and professional regulation.

Key provisions and changes

  • 191.226: DHSS would pay for HIV testing (now framed as testing for sexually transmitted infections/diseases) for rape, sodomy, or incest victims. Testing limited to two rounds per year and aligned with best medical guidance; conducted by the public health laboratory. Cost coverage capped for five years after the crime.
  • 191.650 et al.: Replaces HIV-specific terminology with broader references to “serious infectious or communicable disease.” Redefines terms (e.g., testing, disclosure, health care facilities, health care professionals) and broadens scope to include other diseases.
  • 191.663: Testing of sexual offenders would be ordered pre-incarceration, with costs taxed to the defendant; victims have rights to access results.
  • 191.694–191.700: Expands universal precautions, infection control training, and ongoing regulatory oversight for health care facilities and professionals. Introduces mandatory infection control training for personnel performing invasive procedures; creates a voluntary evaluation process for infected health care professionals to determine permissible practice and restrictions, with confidentiality protections.
  • 191.703: Requires notification to funeral establishment personnel and coroner/ME when a deceased patient had a serious infectious or contagious disease, preserving confidentiality.
  • 338.010 and 338.730: Pharmacy scope expanded to include vaccination administration by protocol and to dispense HIV pre-exposure and post-exposure prophylaxis (as per CDC guidelines) under physician protocol; vaccines may be delivered during public health emergencies; enhanced training and ShowMeVax data entry requirements; patient consent and post-administration reporting provisions included.
  • 375.1300: Clarifies genetic information and insurer practices; permits insurers to conduct HIV testing only for insurance fitness assessments; sets standards for disclosure and confidentiality of test results; requires reporting of positive results to DHSS if no designated physician.
  • 442.600: Revises “psychologically impacted real property” to remove HIV/AIDS language and define property impacted by infection with any disease deemed unlikely to be transmitted in occupancy; limits real estate disclosure liability.
  • 567.020, 567.120, 595.226: Removes HIV-specific penalties and references from prostitution-related offenses and related sentencing/testing provisions; generally reduces HIV-specific criminal penalties and shifts toward broader enforcement mechanisms.

Who and what is affected

  • Health care facilities and professionals, including infection control training and regulated practice changes.
  • Pharmacists and pharmacy protocol-based vaccine and prophylaxis administration.
  • Offenders and juveniles in criminal cases involving sexual offenses or prostitution-related offenses (testing and costs).
  • Insurance regulators, insurers, and policyholders concerning HIV testing and disclosure standards.
  • Real estate professionals and buyers concerning psychologically impacted property disclosures.
  • DHSS, along with other licensing boards, in rulemaking and oversight responsibilities.

Procedural and timeline aspects

  • The bill repeals numerous existing sections and enacts fourteen new sections to read as described.
  • Requires rulemaking by relevant boards (pharmacy and healing arts) with coordinated CDC-aligned guidelines.
  • Testing-related costs and disclosures include specific timing (e.g., reporting post-vaccine administration within 14 days) and confidentiality safeguards.
  • The measure references actions during emergencies (state/federal public health emergencies) for vaccine administration.

Note: This summary focuses on substantive content and potential impact based on the bill text and accompanying notes.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.